Friday, Apr 26 2024 | Time 03:14 Hrs(IST)
image
Business EconomyPosted at: Apr 16 2021 8:23PM


Shatplus, a ray of hope for healthy body and improved immunity

Pune, Apr 16 (UNI) Bharat Vikas Group (BVG), Life Sciences Limited, a next generation health and wellness company, aims to develop eco-friendly Sat innovative evidence based herbals and phytopharmaceuticals for better healthcare, a release said on Friday.
Traditional knowledge and Ayurveda based medicines with scientific validations are the need of current drug discovery community.
With years of rigorous R&D, BVG has come up with ‘ShatPlus, a blend of Ayurveda-based knowledge and Modern science techniques specifically designed to strengthen the immune system and fight against various viral and bacterial infections, release told.
During the research studies, it was observed that ShatPlus is completely safe for uses, have anti-oxidative, anti-inflammatory, anti-viral and immunomodulatory properties.
Addressing the crowded press conference here today, H R Gaikwad, Chairman and managing director of BVG here today said with the emergence of COVID-19 pandemic in 2019-2020 BVG focused its research on COVID-19 management and established positive outcomes for ShatPlus. ShatPlus showed more than 94 percent reduction in the SARS-CoV Viral Load in laboratory tests.
A CTRI registered clinical trial of ShatPlus was conducted on COVID-19 patients (n=60) at Dr. Naidu Infectious Diseases Hospital, he apprised.

It was concluded that ShatPlus as adjuvant therapy showed rapid recovery of COVID-19 patients. Within 4th Day of treatment 73.3%, 7th Day of treatment 96.7% and 10th Day 100% patients recovered in ShatPlus Treatment Group.
ShatPlus treatment showed positive effects on the indicators of immunity in comparison to Standard Treatment group, he added.

ShatPlus treatment also improved other symptoms such as cough, breathlessness etc. and was found to be 100% safe without any adverse effects.
ShatPlus is a clinically validated ayurvedic proprietary medicine that seems to prevent and fights against viral infections.
In current pandemic of COVID-19 which is spreading at a rapid rate, the role of body’s defense system is very crucial and is the need of hour. ShatPlus can play vital role in the prevention and protection against contagious diseases as an Adjuvant therapy, told Mr Gaikwad.
He further said that the vision of BVG is to provide effective and quality products to the global society in the service of mankind.
He also emphasized to explore and develop healthcare solutions based on established and proven traditional ayurvedic knowledge systems.
Dr. Pawan K Singh, Vice President BVG Life Sciences said that the aim of BVG is to develop innovative herbal health products which are based on ayurvedic concepts and fortified with modern scientific techniques.
UNI SP KAZ SHK2031
Please log in to get detailed story.
Tags: #Shatplus# a ray of hope for healthy body and improved immunity
More News

Arun Alagappan appointed as Executive Chairman of Coromandel International

25 Apr 2024 | 7:41 PM

Hyderabad, April 25 (UNI) Arun Alagappan has been appointed as Executive Chairman of Coromandel International Limited (CIL).

see more..

Tech Mahindra net at Rs 661 crore in Q4; Company gives dividend of Rs 28 per share

25 Apr 2024 | 7:28 PM

New Delhi, April 25 (UNI) Mahindra Group company Tech Mahindra, a technology consulting and digital solutions provider, on Thursday reported about 41 per cent decline in net profit at Rs 661 crore year-on-year basis for the fourth quarter ended March 31, 2024.

see more..

Kottayam-Kochi Rubber Market Rates

25 Apr 2024 | 7:26 PM

Kottayam, April 25 (UNI) Following were the Rubber Market rates announced by the Rubber Board here today per quintal.

see more..
Indusind Bank net up 15 pc in Q4

Indusind Bank net up 15 pc in Q4

25 Apr 2024 | 7:10 PM

New Delhi, April 25 (UNI) Leading private bank Indusind on Thursday reported a 15 percent jump in net profit at Rs 2,349 crore in Q4 of FY 2023–24, compared to Rs 2,043 crore in the same quarter in 2022–23.

see more..

25 Apr 2024 | 6:53 PM

New Delhi, April 25 (UNI) Leading private bank Indusind on Thursday reported 15 percent jump in net profit at Rs 2,349 crore in Q4 of FY 2023-24 compared to Rs 2,043 crore in the same quarter in 2022-23.

see more..
image